Clinical Trials Logo

Clinical Trial Summary

The study aims at assessing effectiveness of offering event-driven Doxy PEP and 4CMenB immunization in MSM/TGW at high STI risk. It plans to offer this STI prevention package to all MSM/TGW in the SHCS who are at risk of STI and then comparing 12-months STI incidence between those accepting and those not accepting the prevention package. The proposal further hosts two interesting sub-studies: One assessing potential effect of Doxy PEP on the microbiome and the other one assessing potential impact of Doxy PEP on TP, MG and CT resistance.


Clinical Trial Description

n/a


Study Design


NCT number NCT06242730
Study type Observational [Patient Registry]
Source University of Zurich
Contact Dominique L Braun, MD
Phone 0041442559196
Email dominique.braun@usz.ch
Status Recruiting
Phase
Start date November 1, 2023
Completion date October 31, 2025